Dedicated to providing intuitive software solutions for medical professionals caring for patients that require chronic opioid therapy.
REMIT is to abstain from enforcing punishment on honest patients that have been mislabeled because of misinterpreted urine tests;
MITIGATE is to avoid or prevent poor medication outcomes (toxicity & death) in patients that are abusing/diverting drugs.
Our mission is to provide unique therapeuti
Our newest product is Naloxotel,
On the way is NOverdose,
Meet our team!
Dr. Jeffrey Fudin
Dr. Nadia Shahzad
According to 2014 by the CDC, clinicians wrote almost 260 million prescriptions for opioid analgesics. Nevertheless, it remains well documented that pain management education in schools of medicine, pharmacy, nursing, and other specialty areas is inadequate with minimal hours dedicated to didactic and clinical learning. Even in various pain-related specialty areas, complex pharmacotherapeutic training is scant in terms of advanced pharmacology and therapeutics, pharmacokinetics, pharmacogenetics, and associated drug interactions with polypharmacy. All of these parameters can affect medication blood levels and ultimately their presence in the urine. There is even less time spent specifically on opioid therapy, appropriate risk stratification techniques, and monitoring.
Since 1990, there have been over 100,000 reported deaths associated with prescribed opioids, and most are associated with concomitant use of benzodiazepines and other substances. Many cases also involve designer synthetic street drugs and other products that are not be detectable by immunoassay urine screens or interfere with the results.